Clinical Trial Update: A Study to Investigate the Influence of Hepatic Impairment on MK-8189 Treatment (MK-8189-012) [Phase 1]

View source ↗

Summary

Phase 1 trial updating on the influence of hepatic impairment on MK-8189 treatment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• MK-8189

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2023-10-06